IVF Hartmann Holding AG (SWX:VBSN)
Switzerland · Delayed Price · Currency is CHF 140.00
-1.00 (-0.71%)
Feb 20, 2026, 5:34 PM CET
IVF Hartmann Holding AG Market Cap
IVF Hartmann Holding AG has a market cap or net worth of 335.77 million as of February 20, 2026. Its market cap has decreased by -4.74% in one year.
Market Cap
335.77M
Enterprise Value
242.23M
Revenue
159.69M
Ranking
n/a
PE Ratio
17.80
Stock Price
140.00
Market Cap Chart
Since February 29, 2000, IVF Hartmann Holding AG's market cap has increased from 4.82M to 335.77M, an increase of 6,860.40%. That is a compound annual growth rate of 17.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 335.77M | -1.40% |
| Dec 30, 2025 | 340.53M | -4.68% |
| Dec 30, 2024 | 357.24M | 34.36% |
| Dec 29, 2023 | 265.89M | -6.28% |
| Dec 30, 2022 | 283.72M | -2.86% |
| Dec 30, 2021 | 292.08M | -34.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 293.65B |
| Novartis AG | 243.06B |
| Lonza Group AG | 37.80B |
| Galderma Group AG | 37.06B |
| Basilea Pharmaceutica AG | 668.66M |
| Newron Pharmaceuticals | 420.31M |
| COLTENE Holding AG | 347.77M |
| DocMorris AG | 261.71M |